Mounjaro has overtaken other GLP-1 medicines to become India’s top-selling brand, as demand for newer diabetes and weight-loss treatments rises
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
